Argentina’s Milei Administration Revokes Pharmaceutical Patent Restrictions
Overview of the Revoked Restrictions Prior to the Javier Milei administration, Argentina faced various stringent pharmaceutical patent restrictions that significantly impacted the industry and public health. Enacted in 2012, these regulations sought to enhance local production of generic medications and control drug pricing. However, they also led to an environment where innovation in the pharmaceutical … Read more